Last 48 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 23.16 | 18.73 | 21.70 | 28.34 | 21.89 | 28.69 | 25.84 | 22.32 | 22.88 | 24.59 | 40.94 | 21.85 | 25.53 | 37.39 | 25.84 | 22.44 | 67.83 | 33.04 | 23.72 | 23.44 | 30.89 |
| — | -34.7% | -16.0% | +26.9% | -4.3% | +16.6% | -36.9% | +2.2% | -10.4% | -34.2% | +58.4% | -2.6% | -62.4% | +13.2% | +8.9% | -4.3% | +119.6% | -43.6% | -27.5% | -20.8% | -55.8% | |
| P/S Ratio | 3.05 | 2.81 | 2.74 | 3.60 | 3.36 | 3.49 | 3.06 | 3.50 | 3.47 | 3.22 | 3.10 | 3.56 | 2.90 | 3.82 | 3.55 | 3.56 | 3.81 | 4.19 | 4.34 | 4.48 | 5.18 |
| — | -19.3% | -10.5% | +3.0% | -3.0% | +8.2% | -1.3% | -1.8% | +19.8% | -15.6% | -12.7% | +0.1% | -24.0% | -8.8% | -18.2% | -20.6% | -26.4% | -24.9% | -20.1% | -7.6% | +16.4% | |
| P/B Ratio | 2.22 | 2.16 | 2.14 | 2.64 | 2.47 | 2.49 | 2.26 | 2.34 | 2.39 | 2.12 | 2.11 | 2.22 | 1.79 | 2.29 | 2.35 | 2.13 | 2.22 | 2.34 | 2.66 | 2.64 | 3.11 |
| — | -13.2% | -5.2% | +13.0% | +3.1% | +17.3% | +7.2% | +5.5% | +33.7% | -7.5% | -10.1% | +4.0% | -19.4% | -2.2% | -11.9% | -19.3% | -28.7% | -32.0% | -22.8% | -10.9% | +15.2% | |
| P/FCF | 20.44 | 21.27 | 12.87 | 14.13 | 65.97 | 51.21 | 13.19 | 13.84 | 52.61 | 54.74 | 11.31 | 13.54 | 115.59 | 56.48 | 14.56 | 22.14 | 48.27 | 46.98 | 21.04 | 18.34 | 27.11 |
| — | -58.5% | -2.4% | +2.1% | +25.4% | -6.5% | +16.6% | +2.2% | -54.5% | -3.1% | -22.3% | -38.9% | +139.5% | +20.2% | -30.8% | +20.7% | +78.0% | -3.6% | -35.3% | -3.1% | +26.0% | |
| EV / EBITDA | 14.53 | 17.42 | 15.23 | 14.65 | 16.32 | 16.75 | 14.88 | 15.17 | 15.81 | 16.57 | 19.05 | 16.28 | 14.44 | 18.22 | 16.05 | 16.13 | 16.56 | 20.15 | 17.04 | 17.26 | 20.68 |
| — | +4.0% | +2.4% | -3.5% | +3.2% | +1.1% | -21.9% | -6.8% | +9.4% | -9.0% | +18.7% | +0.9% | -12.8% | -9.6% | -5.8% | -6.6% | -19.9% | -38.7% | -22.3% | -23.4% | -17.0% | |
| EV / EBIT | 21.17 | 17.42 | 16.57 | 24.74 | 20.88 | 24.87 | 23.60 | 20.56 | 20.29 | 22.40 | 30.77 | 20.90 | 19.46 | 26.29 | 20.72 | 21.66 | 22.71 | 29.91 | 23.03 | 23.31 | 28.42 |
| — | -30.0% | -29.8% | +20.4% | +2.9% | +11.0% | -23.3% | -1.6% | +4.3% | -14.8% | +48.5% | -3.5% | -14.3% | -12.1% | -10.0% | -7.1% | -20.1% | -42.3% | -21.6% | -27.9% | -29.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.0% | 65.0% | 75.9% | 64.9% | 60.3% | 57.7% | 64.7% | 66.5% | 64.9% | 65.1% | 64.6% | 65.6% | 65.4% | 65.9% | 65.1% | 65.2% | 66.6% | 65.9% | 68.0% | 68.3% | 68.2% |
| — | +12.7% | +17.2% | -2.4% | -7.1% | -11.5% | +0.3% | +1.3% | -0.7% | -1.2% | -0.9% | +0.6% | -1.7% | +0.0% | -4.2% | -4.6% | -2.3% | -2.4% | +0.5% | +3.1% | +5.5% | |
| Operating Margin | 17.8% | 18.1% | 15.9% | 19.7% | 18.8% | 16.8% | 16.1% | 19.9% | 19.0% | 16.1% | 12.3% | 18.3% | 16.8% | 16.5% | 18.3% | 18.0% | 18.5% | 15.3% | 20.7% | 21.4% | 19.9% |
| — | +7.3% | -0.9% | -1.0% | -0.9% | +4.3% | +31.2% | +8.3% | +13.1% | -1.9% | -33.1% | +1.8% | -9.3% | +7.9% | -11.3% | -15.7% | -7.1% | +41.9% | +5.4% | +30.1% | +63.8% | |
| Net Margin | 13.2% | 15.1% | 12.7% | 12.7% | 15.3% | 12.1% | 11.8% | 15.6% | 15.1% | 13.2% | 7.6% | 16.3% | 11.4% | 10.3% | 13.8% | 15.8% | 5.6% | 12.6% | 18.4% | 19.1% | 16.7% |
| — | +24.3% | +7.0% | -18.8% | +1.5% | -7.9% | +55.5% | -4.5% | +32.7% | +28.2% | -44.8% | +3.3% | +102.2% | -18.5% | -24.8% | -17.0% | -66.3% | +31.9% | +10.4% | +16.7% | +161.3% |
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.8% | 2.9% | 2.5% | 2.3% | 2.8% | 2.2% | 2.2% | 2.6% | 2.6% | 2.1% | 1.3% | 2.6% | 1.8% | 1.5% | 2.3% | 2.4% | 0.8% | 1.8% | 2.8% | 2.8% | 2.5% |
| — | +35.0% | +15.9% | -11.4% | +8.1% | +2.1% | +69.1% | +3.2% | +48.6% | +37.7% | -44.1% | +8.2% | +116.4% | -12.9% | -19.0% | -16.5% | -67.7% | +19.3% | +6.1% | +12.5% | +160.2% | |
| ROA | 5.2% | 1.6% | 1.3% | 1.3% | 1.5% | 1.1% | 1.2% | 1.4% | 1.4% | 1.2% | 0.7% | 1.5% | 1.0% | 0.9% | 1.3% | 1.3% | 0.5% | 1.0% | 1.6% | 1.6% | 1.4% |
| — | +38.5% | +15.8% | -13.0% | +6.7% | -1.8% | +60.9% | -1.6% | +40.5% | +33.2% | -43.2% | +12.0% | +115.6% | -15.2% | -21.6% | -19.1% | -67.4% | +24.4% | +13.6% | +22.6% | +177.2% | |
| ROIC | 6.4% | 1.7% | 1.5% | 1.7% | 1.7% | 1.4% | 1.4% | 1.6% | 1.6% | 1.3% | 1.1% | 1.5% | 1.3% | 1.3% | 1.6% | 1.4% | 1.4% | 1.1% | 1.7% | 1.7% | 1.6% |
| — | +19.4% | +7.0% | +6.2% | +4.4% | +12.2% | +36.5% | +11.2% | +19.1% | +1.2% | -32.7% | +5.2% | -6.4% | +10.7% | -7.7% | -16.0% | -9.0% | +32.9% | +6.3% | +30.6% | +64.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.56 | 0.55 | 0.56 | 0.57 | 0.60 | 0.59 | 0.59 | 0.54 | 0.58 | 0.58 | 0.50 | 0.48 | 0.49 | 0.49 | 0.47 | 0.54 | 0.51 | 0.44 | 0.46 | 0.48 | 0.49 |
| — | -6.9% | -5.5% | +6.4% | +2.4% | +2.7% | +19.1% | +10.7% | +19.7% | +19.0% | +5.2% | -11.1% | -5.0% | +10.4% | +3.1% | +14.2% | +4.1% | -12.3% | -10.6% | -19.9% | -17.6% | |
| Debt / EBITDA | 2.97 | 14.40 | 12.77 | 10.48 | 12.80 | 13.05 | 12.53 | 11.42 | 12.48 | 14.36 | 14.66 | 11.81 | 12.47 | 12.88 | 10.86 | 13.58 | 12.83 | 12.94 | 10.22 | 10.79 | 11.44 |
| — | +10.4% | +2.0% | -8.2% | +2.6% | -9.2% | -14.5% | -3.3% | +0.1% | +11.5% | +35.0% | -13.0% | -2.8% | -0.5% | +6.2% | +25.9% | +12.1% | -23.7% | -11.3% | -30.4% | -38.9% | |
| Current Ratio | 2.13 | 2.07 | 2.13 | 2.54 | 2.42 | 2.01 | 1.85 | 1.90 | 1.84 | 2.13 | 2.03 | 2.30 | 2.29 | 2.42 | 2.39 | 1.76 | 1.76 | 1.58 | 1.86 | 2.61 | 2.91 |
| — | +2.6% | +15.0% | +33.3% | +31.3% | -5.6% | -9.1% | -17.3% | -19.5% | -11.7% | -15.1% | +30.7% | +30.2% | +53.4% | +28.7% | -32.6% | -39.7% | -45.5% | -29.8% | +24.2% | +35.1% | |
| Quick Ratio | 1.62 | 2.09 | 1.62 | 2.62 | 1.80 | 2.05 | 1.42 | 1.43 | 1.39 | 1.61 | 1.55 | 1.71 | 1.69 | 1.79 | 1.81 | 1.39 | 1.41 | 1.23 | 1.49 | 2.10 | 2.36 |
| — | +2.0% | +13.5% | +83.5% | +29.1% | +27.3% | -8.1% | -16.7% | -17.7% | -10.3% | -14.4% | +23.7% | +20.2% | +45.2% | +21.6% | -34.1% | -40.3% | -47.2% | -30.6% | +20.8% | +31.9% | |
| Interest Coverage | 9.58 | 10.51 | 11.37 | 8.76 | 9.82 | 8.39 | 8.25 | 9.60 | 8.46 | 8.59 | 5.23 | 8.83 | 8.29 | 9.08 | 9.29 | 9.23 | 12.82 | 7.37 | 12.20 | 12.60 | 11.98 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MDT stock.
Medtronic plc's current P/E is 23.2x. The average P/E over the last 4 quarters is 22.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Medtronic plc's current operating margin is 17.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Medtronic plc's business trajectory between earnings reports.